Back to Market Feed

BORTEZOMIB 3.5 MG VIAL

Bortezomib
$43.3460per EA
Discontinued

Strength

3.5 mg/1

NDC

50742048401

Classification

Generic

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route

INTRAVENOUS; SUBCUTANEOUS

Last Updated

3/19/2025

Active Ingredients

BORTEZOMIB

Approval Type

Generic (ANDA)

FDA Application

ANDA210824

On Market Since

5/1/2022

Pharmacological Classes

Proteasome Inhibitor
Proteasome Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

+46.2%

Generic Alternatives

8 alternatives • Same active ingredient

BORTEZOMIB 3.5 MG VIAL
Generic
68001054036•BluePoint Laboratories
$43.3460
BORTEZOMIB 3.5 MG VIAL
Generic
31722030331•Camber Pharmaceuticals Inc.
$43.3460
BORTEZOMIB 3.5 MG VIAL
Generic
43598042660•Dr. Reddy's Laboratories Inc.
$43.3460
BORTEZOMIB 3.5 MG VIAL
Generic
63323082110•Fresenius Kabi USA, LLC
$43.3460
BORTEZOMIB 3.5 MG VIAL
Generic
00409170001•Hospira Inc.
$43.3460
BORTEZOMIB 3.5 MG VIAL
Generic
71288011810•Meitheal Pharmaceuticals Inc.
$43.3460
BORTEZOMIB 3.5 MG VIAL
Generic
72603027001•NorthStar Rx LLC
$43.3460
BORTEZOMIB 3.5 MG VIAL
Generic
72205018301•Novadoz Pharmaceuticals LLC
$43.3460

Related Drugs

Same classification

BORTEZOMIB 3.5 MG VIAL
Generic
00143909801•Hikma Pharmaceuticals USA Inc.
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
55150033701•Eugia US LLC
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
60505605004•Apotex Corp.
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
70710141101•Zydus Pharmaceuticals (USA) Inc.
$43.3460
per EA